| Document |
Document Title |
|
WO/2018/168232A1 |
[Problem] A problem was presented in that conventional photochromic compounds cannot be considered adequate in terms of the coloring/decoloring rate and durability, and the production process therefor has many steps. The present inventio...
|
|
WO/2018/162651A1 |
The invention provides a compound of formula (I) wherein: A, B, C, D, W, X, Y and Z are each independently selected from H and OH; or a salt thereof; for use in the treatment and/or prophylaxis of a condition, disease or disorderin a sub...
|
|
WO/2018/162650A1 |
The invention provides a compound of formula (I) wherein: A, B, C, D, W, X, Y and Z are each independently selected from H and OH; or a salt thereof; for use in the treatment and/or prophylaxis of a condition, disease or disorderin a sub...
|
|
WO/2018/160022A1 |
The present disclosure relates to an organic electroluminescent device. The organic electroluminescent device of the present disclosure comprises a specific combination of a light-emitting layer and an electron transport zone, thereby pr...
|
|
WO/2018/159707A1 |
Provided is a method for purifying a substance, which includes: a step for preparing a solution that contains a solvent and one or more substances selected from a compound represented by formula (1A) and a resin having a structure repres...
|
|
WO/2018/159970A1 |
The present disclosure relates to an organic electroluminescent device comprising a light-emitting layer and a hole transport zone. By comprising a specific combination of a light-emitting layer and a hole transport zone, it is possible ...
|
|
WO/2018/152637A1 |
The current application relates to a method for forming a vaporizable liquid composition comprising a cannabinoid distillate from a plant product and 1,3 -propanediol as a mixing or cutting agent. The liquid composition is devoid of poly...
|
|
WO/2018/149857A1 |
The present invention relates to novel 2-oxo-2H-chromen compounds, particularly to compounds comprising a photoactive unit, said novel compounds being particularly suitable for compositions and ophthalmic devices as well as to compositio...
|
|
WO/2018/149855A1 |
The present invention relates to novel compounds, particularly to compounds comprising a photoactive unit, said novel compounds being particularly suitable for compositions and ophthalmic devices as well as to compositions and ophthalmic...
|
|
WO/2018/149850A1 |
The present invention relates to novel compounds, particularly to compounds comprising a photoactive unit, said novel compounds being particularly suitable for compositions and ophthalmic devices as well as to compositions and ophthalmic...
|
|
WO/2018/148816A2 |
The invention describes novel and inventive isolated compounds and the process of producing compounds and extracts with immunosuppressive activity, from plants of the genus Stachytarpheta. In this way, the present application also descri...
|
|
WO/2018/151261A1 |
[Problem] To provide a vitamin E production method and a vitamin E production device capable of increasing the purity of vitamin E in a vitamin E concentrate. [Solution] A raw material oil supply part 1 supplies a raw material oil to a s...
|
|
WO/2018/145213A1 |
Pharmaceutical compositions comprising cannabidiol (CBD), tetrahydrocannabinol (THC), and select omega-3 fatty acids are provided. The CBD and THC are present in a weight ratio of CBD:THC of 10:1 to 20:1. The omega-3 fatty acids comprise...
|
|
WO/2018/145342A1 |
Disclosed in the present invention is a method for preparing dihydrodaidzein, comprising the following steps: (1) using the compound represented by formula I as a raw material for an oxidation reaction to prepare a compound represented b...
|
|
WO/2018/148430A1 |
Methods and apparatuses for reducing the bioburden of cannabis using low-pressure radiant energy processing. The present invention achieves sufficient microbial killing and/or adequate drying without impacting product quality (terpene lo...
|
|
WO/2018/141263A1 |
A penicilones derivative and an application thereof as an anti-resistant bacteria drug, in particular relating to a compound of formula I, stereoisomers thereof, tautomers thereof, solvates thereof, prodrugs thereof, and pharmaceutically...
|
|
WO/2018/141050A1 |
The present invention relates to dosage forms for the production of flash-melt cannabis resin and extract oral dosage forms.
|
|
WO/2018/140738A1 |
Provided are compounds of Formula I, or pharmaceutically acceptable salts thereof, which are activators of nuclear factor erythroid 2 (NF-E2) -related factor 2 (Nrf2) and are useful to treat diseases caused by oxidative stress, such as n...
|
|
WO/2018/132893A1 |
The present invention relates to immediate release pharmaceutical compositions comprising one or more natural or synthetic cannabinoids, and one or more pharmaceutically acceptable excipients. More specifically, the invention relates to ...
|
|
WO/2018/135498A1 |
The present invention provides a compound represented by formula (O).
|
|
WO/2018/120971A1 |
Provided is a coumarin green light dye containing a triphenylamine ethylene side chain. The green light dye has a structure shown in formula (I), wherein R1, R2 and R3 independently represent hydrogen, a C1-C8 substituted or unsubstitute...
|
|
WO/2018/125880A1 |
Provided are compounds of Formula I, or pharmaceutically acceptable salts thereof, and methods for their use and production.
|
|
WO/2018/115582A1 |
The invention relates to process for converting plant material to plant extract having antimicrobial activity, said process comprising the steps, where in the first step at least one plant material is ground in the presence of a first me...
|
|
WO/2018/116054A1 |
The present invention relates to new compounds deriving from spermatophyte plants belonging to the Hypericaceae family, in particular from Hypericum mexicanum having a fungicidal activity, and relative pharmaceutical compositions and use...
|
|
WO/2018/113201A1 |
A compound as represented by formula (I), or a stereoisomer, a tautomer thereof, a pharmaceutically acceptable salt thereof, a solvate thereof, or a prodrug thereof, a preparation method therefor, a pharmaceutical composition comprising ...
|
|
WO/2018/119263A1 |
Disclosed are compounds of Formula (I'), methods of using the compounds as immunomodulators, and pharmaceutical compositions comprising such compounds. The compounds inhibit PD-1/PD-L1 interaction and are useful in treating, preventing o...
|
|
WO/2018/118058A1 |
Method of isolating natural molecules: α and β pyranocycloartobiloxanthone A and Artonine E, from the stem bark of Artocarpus hirsutus and their anti-acne potential by inhibiting the growth of Propionibacterium acnes thereof, are descr...
|
|
WO/2018/107289A1 |
Compounds described herein are inhibitors of retinoic acid inducible P450 (CYP26) enzymes, and are useful for treating diseases that are responsive to retinoids. Certain compounds have retinoid activity, are resistant to CYP26-mediated c...
|
|
WO/2018/109780A1 |
The invention relates to a process for the preparation of tocols [tocopherols (T) and tocotrienols (T3)] and squalene from vegetable oil refining by- products like fatty acid distillates. It particularly relates to the process of prepara...
|
|
WO/2018/108606A1 |
The present invention is directed to a process for the manufacture of 6,10-dimethylundecan-2-one comprising the step of hydrogenating (5Z)-nerylacetone with hydrogen in the presence of a catalyst, whereby the catalyst is capable of prefe...
|
|
WO/2018/103239A1 |
Disclosed is a preparation method for a compound shown by formula (E), a Velpatasvir intermediate shown by formula (K) and an analogue thereof. The method of the present invention uses inexpensive and easily available materials, and a si...
|
|
WO/2018/106518A1 |
Novel compounds of the structural formula (I), and the pharmaceutically acceptable salts thereof, are agonists of G-protein coupled receptor 40 (GPR40) and may be useful in the treatment, prevention and suppression of diseases mediated b...
|
|
WO/2018/099836A1 |
An object is to provide a planarizing coating-forming composition having high etching resistance and good gap filling property. Another object is to provide a method for manufacturing a device using the planarizing coating-forming compos...
|
|
WO/2018/099431A1 |
Disclosed is a pyrene organic compound having the following structural formula. The pyrene organic compound has better charge transfer performance and luminous efficiency, and also has better thermal stability. Therefore, by providing an...
|
|
WO/2018/101377A1 |
The present invention provides a compound having a specific structure represented by formula (0), a resin having a constituent unit derived from said compound, various compositions containing said compound and/or said resin, and various ...
|
|
WO/2018/099432A1 |
The present invention relates to a fused ring compound and a preparation method and application thereof. The fused ring compound is represented by general formula (I). The fused ring compound emits fluorescence at a short wavelength, and...
|
|
WO/2018/101207A1 |
The present invention addresses the problem of providing: a polymerizable liquid crystal composition that makes it possible to manufacture an optical film that has excellent light resistance; and an optically anisotropic membrane, an opt...
|
|
WO/2018/101463A1 |
The present invention is a compound having a specific structure, a resin having structural units derived from said compound, various compositions containing said compound and/or said resin, and various methods in which said compositions ...
|
|
WO/2018/101376A1 |
The present invention is a compound having a specific structure represented by formula (0), a resin having structural units derived from said compound, various compositions containing said compound and/or said resin, and various methods ...
|
|
WO/2018/099848A1 |
An object is to provide a planarizing coating-forming composition that exhibits high etching resistance, good gap filling property, and high flatness. Another object is to provide a method for manufacturing a device using the planarizing...
|
|
WO/2018/095132A1 |
An electroplating copper layer includes bamboo-like copper crystal particles having a highly preferred orientation. The bamboo-like copper crystal particles have a long axis direction and a short axis direction, and the bamboo-like coppe...
|
|
WO/2018/097215A1 |
The present invention is: a compound having a specific structure; a resin having a structural unit derived from the compound; various compositions containing the compound and/or the resin; and various methods in which the composition is ...
|
|
WO/2018/091756A1 |
The present invention relates to bioconjugates and derivatives of ochratoxin A labelled at different positions in the molecule suitable for the production of antibodies with a high affinity for ochratoxin A. Moreover, the present inventi...
|
|
WO/2018/092921A1 |
The present invention provides compounds of formula (I) and pharmaceutically acceptable salts thereof wherein Z, R1, R2, R3, R4, R5 and R6 are as defined in the specification, a process for their preparation, pharmaceutical compositions ...
|
|
WO/2018/087126A1 |
The present invention relates to amido-substituted cyclohexane compounds of general formula (I), in which A, R4, R6, R7, R8, R9, R10 and R11 are as defined herein, to methods of preparing said compounds, to intermediate compounds useful ...
|
|
WO/2018/089400A1 |
Methods of treatment of MIF-related diseases and methods of MIF inhibition are provided.
|
|
WO/2018/083635A3 |
Disclosed are tricyclic heterocyclic compounds having kinase inhibitory activity, pharmaceutical compositions and kits comprising the compounds, and use of the compounds in the treatment of or in medicaments for the treatment of various ...
|
|
WO/2018/085787A1 |
A photocatalyst can be regenerated with increasing efficiency, turnover number and turnover frequency in the presence of air by irradiating the photocatalyst, preferably eosin Y, with a first range of wavelengths of light that excite the...
|
|
WO/2018/083713A1 |
The present invention discloses a novel, stable and synergistic combination of epicatechin with anti-cancer compounds. The present invention also discloses a composition comprising the novel combination of epicatechin with anti-cancer co...
|
|
WO/2018/080066A1 |
The present invention relates to a new compound and an organic electroluminescent device comprising the same. As the compound according to the present invention is used for an organic layer of an organic electroluminescent device, and pr...
|
